Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
VISION Pilot Trial: Dexamethasone vs. Placebo in Orbital Cellulitis
NCT07345819Not yet recruiting
- Sponsor
- SickKids
- Start
- Apr 2026
- Primary completion
- Sep 2027
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Randomised, double-blind trial of dexamethasone in orbital cellulitis (2 arms), sponsored by SickKids. Primary endpoint: Recruitment rate at 18 months. Planned start Apr 2026; status: not yet recruiting.
02
Drugs
dexamethasone
03
Conditions
orbital cellulitis
Beyond the preview
Go deeper on NCT07345819.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07345819.